BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22935974)

  • 1. Mitogen-activated protein kinase pathway in osteosarcoma.
    Na KY; Kim YW; Park YK
    Pathology; 2012 Oct; 44(6):540-6. PubMed ID: 22935974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma.
    Chen L; Shi Y; Jiang CY; Wei LX; Wang YL; Dai GH
    Eur J Surg Oncol; 2011 Jun; 37(6):513-20. PubMed ID: 21324414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.
    Chen L; Wang Q; Wang GD; Wang HS; Huang Y; Liu XM; Cai XH
    FEBS Lett; 2013 May; 587(9):1366-72. PubMed ID: 23507142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation.
    Sippel RS; Chen H
    Surgery; 2002 Dec; 132(6):1035-9; discussion 1039. PubMed ID: 12490852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of Raf-1 kinase, phosphorylated mitogen extracellular kinase 1, and phosphorylated extracellular signal-regulated protein kinase 1/2 in hepatocellular carcinoma and their relationship with prognosis].
    Chen L; Shi Y; Jiang CY; Sun Q; Dai GH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):424-8. PubMed ID: 20868603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients.
    McGlynn LM; Kirkegaard T; Edwards J; Tovey S; Cameron D; Twelves C; Bartlett JM; Cooke TG
    Clin Cancer Res; 2009 Feb; 15(4):1487-95. PubMed ID: 19228750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway.
    Gilbert SJ; Blain EJ; Duance VC; Mason DJ
    Arthritis Rheum; 2008 Jan; 58(1):209-20. PubMed ID: 18163502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene profiling of MAPK pathway in human osteosarcoma].
    Li GD; Cai ZD; Zhang YQ; Gong HY; Tang H; Zhang QL
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):340-5. PubMed ID: 19799081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone inhibits phosphorylation of mitogen-activated protein kinase (MAPK) ERK1/2 through inhibition of c-Raf and activation of MKP-1 in osteoblastic cells.
    Lai LP; Mitchell J
    Cell Biochem Funct; 2009 Jul; 27(5):269-75. PubMed ID: 19384851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf: a strategic target for therapeutic development against cancer.
    Beeram M; Patnaik A; Rowinsky EK
    J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the signaling pathways that underpin capacitation-associated surface phosphotyrosine expression in mouse spermatozoa.
    Nixon B; Bielanowicz A; Anderson AL; Walsh A; Hall T; Mccloghry A; Aitken RJ
    J Cell Physiol; 2010 Jul; 224(1):71-83. PubMed ID: 20232304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
    Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
    J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
    Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
    Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.